Soheil S Dadras

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
    Mod Pathol 18:1232-42. 2005
  2. pmc Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors
    Vivien Schacht
    Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    Am J Pathol 166:913-21. 2005
  3. ncbi request reprint Infantile hemangiomas are arrested in an early developmental vascular differentiation state
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
    Mod Pathol 17:1068-79. 2004
  4. ncbi request reprint Angiogenesis and lymphangiogenesis of skin cancers
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
    Hematol Oncol Clin North Am 18:1059-70, viii. 2004
  5. pmc Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
    Am J Pathol 162:1951-60. 2003
  6. ncbi request reprint An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo
    Yun Hee Noh
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
    J Invest Dermatol 121:1536-43. 2003
  7. ncbi request reprint Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity
    Paula E North
    Departments of Pathology and Otolaryngology, the University of Arkansas for Medical Sciences and Arkansas Children s Hospital, Little Rock, AR 72202, USA
    Arch Dermatol 140:599-606. 2004
  8. ncbi request reprint Primary orbital melanoma associated with an occult episcleral nevus
    John T H Mandeville
    Arch Ophthalmol 122:287-90. 2004
  9. pmc Inflammatory manifestations of experimental lymphatic insufficiency
    Raymond Tabibiazar
    Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States of America
    PLoS Med 3:e254. 2006
  10. ncbi request reprint F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid
    Ryan D Niederkohr
    Division of Nuclear Medicine, Stanford University Medical Center, Stanford University Hospital and Clinics, Stanford, CA 94305 5281, USA
    Clin Nucl Med 32:162-4. 2007

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
    Mod Pathol 18:1232-42. 2005
    ..Assessment of lymphangiogenesis in primary melanomas may be a more effective approach than the currently used technique of measuring tumor thickness in selecting patients with early metastatic disease for aggressive therapy...
  2. pmc Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors
    Vivien Schacht
    Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    Am J Pathol 166:913-21. 2005
    ....
  3. ncbi request reprint Infantile hemangiomas are arrested in an early developmental vascular differentiation state
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
    Mod Pathol 17:1068-79. 2004
    ..The immature, incompletely differentiated immunophenotype of proliferating infantile hemangiomas may contribute to their rapid growth during the first few months of life...
  4. ncbi request reprint Angiogenesis and lymphangiogenesis of skin cancers
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA
    Hematol Oncol Clin North Am 18:1059-70, viii. 2004
    ..A better molecular understanding of the lymphatic system may provide new insights into the biology of tumor metastasis and may provide novel prognostic and therapeutic tools in metastatic disease...
  5. pmc Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival
    Soheil S Dadras
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
    Am J Pathol 162:1951-60. 2003
    ..Our results reveal tumor lymphangiogenesis as a novel prognostic indicator for the risk of lymph node metastasis in cutaneous melanoma...
  6. ncbi request reprint An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo
    Yun Hee Noh
    Cutaneous Biology Research Center and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
    J Invest Dermatol 121:1536-43. 2003
    ..These findings identify TSP-2/NTF as a potent systemic inhibitor of tumor growth and angiogenesis, acting by direct inhibition of several endothelial cell functions involved in neovascularization...
  7. ncbi request reprint Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity
    Paula E North
    Departments of Pathology and Otolaryngology, the University of Arkansas for Medical Sciences and Arkansas Children s Hospital, Little Rock, AR 72202, USA
    Arch Dermatol 140:599-606. 2004
    ..We studied the clinical and histopathologic features of 3 patients demonstrating this previously uninvestigated phenomenon...
  8. ncbi request reprint Primary orbital melanoma associated with an occult episcleral nevus
    John T H Mandeville
    Arch Ophthalmol 122:287-90. 2004
  9. pmc Inflammatory manifestations of experimental lymphatic insufficiency
    Raymond Tabibiazar
    Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, United States of America
    PLoS Med 3:e254. 2006
    ..Sustained lymph stagnation engenders a pathological response that is complex and not well characterized. Tissue inflammation in lymphedema may reflect either an active or passive consequence of impaired immune traffic...
  10. ncbi request reprint F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid
    Ryan D Niederkohr
    Division of Nuclear Medicine, Stanford University Medical Center, Stanford University Hospital and Clinics, Stanford, CA 94305 5281, USA
    Clin Nucl Med 32:162-4. 2007
  11. doi request reprint Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study
    Ankur R Sangoi
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Am J Surg Pathol 32:261-8. 2008
    ..The presence of LVI in microinvasive S-LMP corroborates the view that microinvasion represents an early, but very low risk, invasive process that morphologically links S-LMP and low-grade serous carcinoma...
  12. doi request reprint Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms
    Chris H Jokinen
    Department of Pathology, University of Washington, Seattle, USA
    Am J Clin Pathol 129:886-93. 2008
    ..These results suggest diffuse podoplanin expression or coexpression of podoplanin and S-100 is limited to schwannoma and EMPNST and may be useful in the evaluation of these neoplasms...